A PLACEBO-CONTROLLED PATENCY STUDY OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX-30U IN ACUTE MYOCARDIAL-INFARCTION

被引：0
|
作者：
DEBONO, DP
机构：
来源：
DRUGS | 1987年 / 33卷
关键词：
D O I：
10.2165/00003495-198700333-00022
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [21] COMPARATIVE TOLERANCE AND COMPLICATIONS IN A MULTICENTER TRIAL OF INTRACORONARY STREPTOKINASE AND INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN ACUTE MYOCARDIAL-INFARCTION
    ROTHBARD, RL
    DRUGS, 1987, 33 : 276 - 278
  • [22] ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS PLACEBO - A PRELIMINARY MULTICENTER STUDY OF SAFETY AND EARLY MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    JULIAN, DG
    BORTHWICK, LS
    REID, D
    JENNINGS, KP
    WAINWRIGHT, RJ
    RODGER, JC
    WOOD, D
    PHILLIPS, WS
    DRUGS, 1987, 33 : 261 - 267
  • [23] ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION - PRELIMINARY-RESULTS OF A RANDOMIZED STUDY
    MONNIER, P
    SIGWART, U
    VINCENT, A
    BACHMANN, F
    GOY, JJ
    SCHALLER, MD
    KAUFMANN, U
    BADAN, M
    GRBIC, M
    PERRET, C
    KAPPENBERGER, L
    DRUGS, 1987, 33 : 175 - 178
  • [24] INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS INTRAVENOUS STREPTOKINASE IN EVOLVING MYOCARDIAL-INFARCTION - PRELIMINARY DATA FROM A RANDOMIZED MULTICENTER STUDY
    BROCHIER, ML
    QUILLIET, L
    KULBERTUS, H
    MATERNE, P
    LETAC, B
    CRIBIER, A
    MONASSIER, JP
    SACREZ, A
    FAVIER, JP
    DRUGS, 1987, 33 : 140 - 145
  • [25] TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN A DISTRICT HOSPITAL - EFFICACY DATA
    CHAMBERLAIN, DA
    DRUGS, 1987, 33 : 221 - 222
  • [26] EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    HELD, PH
    TEO, KK
    YUSUF, S
    CIRCULATION, 1990, 82 (05) : 1668 - 1674
  • [27] EUROPEAN MULTICENTER RANDOMIZED STUDY OF APSAC (ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX) VERSUS STREPTOKINASE IN MYOCARDIAL-INFARCTION
    CHARBONNIER, B
    CRIBIER, A
    MONASSIER, JP
    FAVIER, JP
    MATERNE, P
    BROCHIER, ML
    LETAC, B
    HANSSEN, M
    SACREZ, A
    KULBERTUS, H
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1989, 82 (09): : 1565 - 1571
  • [28] THE GERMAN MULTICENTER TRIAL OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS HEPARIN FOR ACUTE MYOCARDIAL-INFARCTION
    MEINERTZ, T
    KASPER, W
    SCHUMACHER, M
    JUST, H
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (07): : 347 - 351
  • [29] TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN A DISTRICT HOSPITAL - TOLERANCE DATA
    CHAMBERLAIN, DA
    DRUGS, 1987, 33 : 286 - 286
  • [30] MULTICENTER REPERFUSION TRIAL OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) AND INTRACORONARY STREPTOKINASE IN MYOCARDIAL-INFARCTION - FINAL REPORT
    ANDERSON, JL
    HACKWORTHY, RA
    ROTHBARD, RL
    SORENSEN, SG
    FITZPATRICK, PG
    MENLOVE, RL
    BARRY, WH
    MARDER, VJ
    CIRCULATION, 1987, 76 (04) : 121 - 121
12345